Results 331 to 340 of about 298,673 (357)

Incidence, Predictors, and Outcomes of Major Transcatheter Aortic Valve Replacement (TAVR) Complications and Failure-to-Rescue in the Contemporary Era. [PDF]

Interdiscip Cardiovasc Thorac Surg
Catalano MA, Bazianos D, Nathan A, Gillinov L, Toubat O, Sperry AE, Goel NJ, Desai ND, Szeto WY, Brown CR, Lawrence KM.   +10 more
europepmc   +1 more source

Transcatheter Aortic Valve Replacement for Treating Native Aortic Regurgitation: Ready for Prime Time? [PDF]

Struct Heart
Guddeti RR, El-Hangouche N, Answini G, Kereiakes D, Garcia S.   +4 more
europepmc   +1 more source

In-Hospital Outcomes of Simultaneous and Staged Transcatheter Aortic Valve Replacement and Endovascular Aneurysm Repair. [PDF]

Catheter Cardiovasc Interv
Pu A, Annabathula RV, Allaham H, Chahal D, Toursavadkohi S, Gupta A.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial

Lancet, The, 2015
D Craig Miller, Emin Murat Tuzcu, John G Webb   +2 more
exaly   +2 more sources

Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis

Lancet, The, 2016
Susheel Kodali, Raj R Makkar, S Chris Malaisrie   +2 more
exaly   +2 more sources

Incidence and feasibility of coronary access after transcatheter aortic valve replacement

Catheterization and cardiovascular interventions, 2020
Incidence of coronary access (CA) after transcatheter aortic valve replacement (TAVR) at long‐term follow‐up remains unknown. CA and percutaneous coronary intervention (PCI) after TAVR might present technical challenges, particularly with supra‐annular ...
L. Nai Fovino, A. Scotti, M. Massussi, T. Fabris, F. Cardaioli, G. Rodinò, Yuji Matsuda, Francesca Frigo, C. Fraccaro, G. Tarantini   +9 more
semanticscholar   +1 more source

Considerations for Optimal Device Selection in Transcatheter Aortic Valve Replacement: A Review.

JAMA cardiology, 2020
Importance Aortic valve stenosis (AS) is the most common manifestation of acquired valvular heart disease in developed countries. Several large-scale randomized clinical trials investigating the entire spectrum of patients with severe symptomatic AS from
B. Claessen, G. Tang, A. Kini, Samin K. Sharma   +3 more
semanticscholar   +1 more source

Patient-prosthesis mismatch following aortic valve replacement

Heart, 2019
Patient-prosthesis mismatch (PPM) occurs when an implanted prosthetic valve is too small for the patient; severe PPM is defined as an indexed effective orifice area (iEOA)
R. Bilkhu, M. Jahangiri, C. Otto
semanticscholar   +1 more source

Valve-in-Valve Transcatheter Aortic Valve Replacement Versus Redo Surgical Aortic Valve Replacement: An Updated Meta-Analysis.

JACC: Cardiovascular Interventions, 2021
M. Sá, Jef Van den Eynde, M. Simonato, L. R. P. Cavalcanti, I. Doulamis, V. Weixler, Polydoros N. Kampaktsis, M. Gallo, P. Laforgia, K. Zhigalov, A. Ruhparwar, A. Weymann, P. Pibarot, M. Clavel   +13 more
semanticscholar   +1 more source

Calcific aortic valve disease: mechanisms, prevention and treatment

Nature Reviews Cardiology, 2023
, Yohan Bossé, Patrick Mathieu
exaly